Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Instruments
1.2.4 Services
1.2.5 Software
1.3 Market by Application
1.3.1 Global Drug Discovery Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Government Institutions
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Assays Market Perspective (2019-2030)
2.2 Drug Discovery Assays Growth Trends by Region
2.2.1 Global Drug Discovery Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Discovery Assays Historic Market Size by Region (2019-2024)
2.2.3 Drug Discovery Assays Forecasted Market Size by Region (2025-2030)
2.3 Drug Discovery Assays Market Dynamics
2.3.1 Drug Discovery Assays Industry Trends
2.3.2 Drug Discovery Assays Market Drivers
2.3.3 Drug Discovery Assays Market Challenges
2.3.4 Drug Discovery Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Assays Players by Revenue
3.1.1 Global Top Drug Discovery Assays Players by Revenue (2019-2024)
3.1.2 Global Drug Discovery Assays Revenue Market Share by Players (2019-2024)
3.2 Global Drug Discovery Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Discovery Assays Revenue
3.4 Global Drug Discovery Assays Market Concentration Ratio
3.4.1 Global Drug Discovery Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Assays Revenue in 2023
3.5 Drug Discovery Assays Key Players Head office and Area Served
3.6 Key Players Drug Discovery Assays Product Solution and Service
3.7 Date of Enter into Drug Discovery Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Assays Breakdown Data by Type
4.1 Global Drug Discovery Assays Historic Market Size by Type (2019-2024)
4.2 Global Drug Discovery Assays Forecasted Market Size by Type (2025-2030)
5 Drug Discovery Assays Breakdown Data by Application
5.1 Global Drug Discovery Assays Historic Market Size by Application (2019-2024)
5.2 Global Drug Discovery Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Discovery Assays Market Size (2019-2030)
6.2 North America Drug Discovery Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Discovery Assays Market Size by Country (2019-2024)
6.4 North America Drug Discovery Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Assays Market Size (2019-2030)
7.2 Europe Drug Discovery Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Discovery Assays Market Size by Country (2019-2024)
7.4 Europe Drug Discovery Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Assays Market Size (2019-2030)
8.2 Asia-Pacific Drug Discovery Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Discovery Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Discovery Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Assays Market Size (2019-2030)
9.2 Latin America Drug Discovery Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Discovery Assays Market Size by Country (2019-2024)
9.4 Latin America Drug Discovery Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Assays Market Size (2019-2030)
10.2 Middle East & Africa Drug Discovery Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Discovery Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Discovery Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Drug Discovery Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Drug Discovery Assays Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Drug Discovery Assays Introduction
11.2.4 Danaher Revenue in Drug Discovery Assays Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Drug Discovery Assays Introduction
11.3.4 Becton Dickinson Revenue in Drug Discovery Assays Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Drug Discovery Assays Introduction
11.4.4 GE Healthcare Revenue in Drug Discovery Assays Business (2019-2024)
11.4.5 GE Healthcare Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Drug Discovery Assays Introduction
11.5.4 Merck Revenue in Drug Discovery Assays Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Lonza
11.6.1 Lonza Company Detail
11.6.2 Lonza Business Overview
11.6.3 Lonza Drug Discovery Assays Introduction
11.6.4 Lonza Revenue in Drug Discovery Assays Business (2019-2024)
11.6.5 Lonza Recent Development
11.7 PerkinElmer, Inc.
11.7.1 PerkinElmer, Inc. Company Detail
11.7.2 PerkinElmer, Inc. Business Overview
11.7.3 PerkinElmer, Inc. Drug Discovery Assays Introduction
11.7.4 PerkinElmer, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.7.5 PerkinElmer, Inc. Recent Development
11.8 Charles River Laboratories, Inc.
11.8.1 Charles River Laboratories, Inc. Company Detail
11.8.2 Charles River Laboratories, Inc. Business Overview
11.8.3 Charles River Laboratories, Inc. Drug Discovery Assays Introduction
11.8.4 Charles River Laboratories, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.8.5 Charles River Laboratories, Inc. Recent Development
11.9 Cell Signaling Technologies
11.9.1 Cell Signaling Technologies Company Detail
11.9.2 Cell Signaling Technologies Business Overview
11.9.3 Cell Signaling Technologies Drug Discovery Assays Introduction
11.9.4 Cell Signaling Technologies Revenue in Drug Discovery Assays Business (2019-2024)
11.9.5 Cell Signaling Technologies Recent Development
11.10 Cisbio
11.10.1 Cisbio Company Detail
11.10.2 Cisbio Business Overview
11.10.3 Cisbio Drug Discovery Assays Introduction
11.10.4 Cisbio Revenue in Drug Discovery Assays Business (2019-2024)
11.10.5 Cisbio Recent Development
11.11 Cell Biolabs, Inc.
11.11.1 Cell Biolabs, Inc. Company Detail
11.11.2 Cell Biolabs, Inc. Business Overview
11.11.3 Cell Biolabs, Inc. Drug Discovery Assays Introduction
11.11.4 Cell Biolabs, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.11.5 Cell Biolabs, Inc. Recent Development
11.12 Promega
11.12.1 Promega Company Detail
11.12.2 Promega Business Overview
11.12.3 Promega Drug Discovery Assays Introduction
11.12.4 Promega Revenue in Drug Discovery Assays Business (2019-2024)
11.12.5 Promega Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Detail
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Drug Discovery Assays Introduction
11.13.4 Pfizer Revenue in Drug Discovery Assays Business (2019-2024)
11.13.5 Pfizer Recent Development
11.14 GSK
11.14.1 GSK Company Detail
11.14.2 GSK Business Overview
11.14.3 GSK Drug Discovery Assays Introduction
11.14.4 GSK Revenue in Drug Discovery Assays Business (2019-2024)
11.14.5 GSK Recent Development
11.15 Agilent
11.15.1 Agilent Company Detail
11.15.2 Agilent Business Overview
11.15.3 Agilent Drug Discovery Assays Introduction
11.15.4 Agilent Revenue in Drug Discovery Assays Business (2019-2024)
11.15.5 Agilent Recent Development
11.16 Eli Lilly and Company
11.16.1 Eli Lilly and Company Company Detail
11.16.2 Eli Lilly and Company Business Overview
11.16.3 Eli Lilly and Company Drug Discovery Assays Introduction
11.16.4 Eli Lilly and Company Revenue in Drug Discovery Assays Business (2019-2024)
11.16.5 Eli Lilly and Company Recent Development
11.17 Roche
11.17.1 Roche Company Detail
11.17.2 Roche Business Overview
11.17.3 Roche Drug Discovery Assays Introduction
11.17.4 Roche Revenue in Drug Discovery Assays Business (2019-2024)
11.17.5 Roche Recent Development
11.18 Bayer
11.18.1 Bayer Company Detail
11.18.2 Bayer Business Overview
11.18.3 Bayer Drug Discovery Assays Introduction
11.18.4 Bayer Revenue in Drug Discovery Assays Business (2019-2024)
11.18.5 Bayer Recent Development
11.19 Abbott
11.19.1 Abbott Company Detail
11.19.2 Abbott Business Overview
11.19.3 Abbott Drug Discovery Assays Introduction
11.19.4 Abbott Revenue in Drug Discovery Assays Business (2019-2024)
11.19.5 Abbott Recent Development
11.20 AstraZeneca
11.20.1 AstraZeneca Company Detail
11.20.2 AstraZeneca Business Overview
11.20.3 AstraZeneca Drug Discovery Assays Introduction
11.20.4 AstraZeneca Revenue in Drug Discovery Assays Business (2019-2024)
11.20.5 AstraZeneca Recent Development
11.21 Shimadzu
11.21.1 Shimadzu Company Detail
11.21.2 Shimadzu Business Overview
11.21.3 Shimadzu Drug Discovery Assays Introduction
11.21.4 Shimadzu Revenue in Drug Discovery Assays Business (2019-2024)
11.21.5 Shimadzu Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details